Skip to main content
Local News

Allen Institute for Immunology Partners with Lilly to Better Understand Autoimmune Disease

By July 26, 2023No Comments

In a significant milestone for the Allen Institute for Immunology, a division of the Allen Institute, researchers and staff will collaborate with private industry researchers to aid in the detailed, molecular understanding of disease, in service of developing new treatments and therapies to improve human health.

Specifically, Allen Institute scientists will work with researchers from Eli Lilly and Company (Lilly) to investigate and profile disease state diversity and biomarkers for drug response involving atopic dermatitis (eczema) and rheumatoid arthritis using Allen Institute-developed unique molecular tools and comprehensive bioinformatic analysis techniques.